Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura

This study has been withdrawn prior to enrollment.

Sponsor:

Collaborator:

Genentech

Information provided by (Responsible Party):

James B. Bussel, Weill Medical College of Cornell University

ClinicalTrials.gov Identifier:

NCT00251277

First received: November 7, 2005

Last updated: November 14, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	April 2009
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)